USPTO serial 99252473
MAKE AMERICANS SEE AGAIN
Reviewed by CopyMark Law Group
Status 730Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- SCHLEGELMILCH, JONATHON A
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with MAKE AMERICANS SEE AGAIN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,246*
Plus Government fees of $600
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
MALVERN, PA, US
MALVERN, PA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Don Cha
Don Cha HDC INTELLECTUAL PROPERTY LAW, LLP14405 W Colfax AveSTE 305Lakewood, CO 80401Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for gene therapy for the treatment of retinal diseases | ACTIVE | — |
| 035 | Online advertising and marketing services in the field of ophthalmology; On-line advertising and marketing services | ACTIVE | — |
| 042 | Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Biotechnology research; Product research; Scientific research; Medical research; Biological research; Providing medical research information in the field of pharmaceuticals; Providing scientific research information in the field of pharmaceuticals; Research and development services in the field of biotechnology; Research in the field of DNA repair technology; Providing information about medical and scientific research via a website; Biochemical research and analysis; Research and development of vaccines and medicines; Research and development in the field of biochemistry; Research and development in the field of biotechnology; Medical research in the field of rare diseases; Biochemical research; Research and development of medicines; Research and development in the pharmaceutical and biotechnology fields; Research on the subject of pharmaceuticals; Research and development of new products; Gene therapy research; Pharmaceutical research and development; Vaccine research and development; Clinical research in the field of ophthalmology; Scientific study and research in the field(s) of ophthalmology; Pharmaceutical research in the field of ophthalmology; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Development of pharmaceuticals for cell and gene therapies | ACTIVE | — |
| 044 | Ophthalmology services; Providing on-line medical record analysis services designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; Providing on-line information, news and commentary in the field of health and wellness relating to ophthalmology | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by OCUGEN, INC.
- Other trademarks owned by OCUGEN, INC.
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named MAKE AMERICANS SEE AGAIN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 4, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 3, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Aug 3, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| Aug 3, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 3, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 9, 2025 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 9, 2025 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 3, 2025 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 13, 2025 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 13, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 31, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 25, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 25, 2025 | NWAP | NEW APPLICATION ENTERED | — |